The Clatterbridge Cancer Centre NHS Foundation Trust
22
5
9
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 22 trials
100.0%
+13.5% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days.
Role: lead
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Role: collaborator
Living Without Answers - ILLUMINATE CUP
Role: lead
Breaking Barriers to Research Access
Role: lead
SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance
Role: collaborator
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Role: collaborator
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Role: collaborator
A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
Role: lead
Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma
Role: collaborator
CITRuS Stage 1; Feasibility
Role: collaborator
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Role: collaborator
A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer
Role: lead
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC
Role: lead
CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Role: lead
CCP Cancer UK Companion Study
Role: lead
Investigation of an Abdominal Compression Device
Role: lead
Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome
Role: lead
Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer
Role: lead
Magnetic Resonance Imaging for Lung Radiotherapy
Role: lead
A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
Role: lead